Therma-Med, Inc.
THRA
$0.00
$0.000.00%
OTC PK
| 09/30/2011 | 06/30/2011 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 615.88% | 69.15% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 589.86% | 64.35% | |||
| Operating Income | -589.86% | -64.35% | |||
| Income Before Tax | -570.57% | -60.96% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -570.57% | -60.96% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -570.57% | -60.96% | |||
| EBIT | -589.86% | -64.35% | |||
| EBITDA | -615.88% | -69.15% | |||
| EPS Basic | 0.00% | 0.00% | |||
| Normalized Basic EPS | -- | 100.00% | |||
| EPS Diluted | 0.00% | 0.00% | |||
| Normalized Diluted EPS | -- | 100.00% | |||
| Average Basic Shares Outstanding | 555.89% | 174.44% | |||
| Average Diluted Shares Outstanding | 555.89% | 174.44% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||